Ardent Health Faces Class Action Lawsuit After $42.6M Revenue Cut, Shares Plunge 33%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 21h ago
0mins
Source: Globenewswire
- Financial Misstep Revealed: Ardent Health disclosed a $42.6 million revenue cut in its Q3 2025 earnings report, leading to a 33% drop in share price the following day, indicating significant flaws in its revenue recognition systems that could undermine investor confidence.
- Lawsuit Initiated: Hagens Berman has filed a securities class action lawsuit against Ardent and its executives, alleging they misled investors about the adequacy of professional liability reserves during the period from July 18, 2024, to November 12, 2025.
- Accounting Method Change: The company revealed a shift in its accounting method, implementing a 180-day cliff for assessing accounts receivable collectability, which contradicts previous assurances and may lead to further financial opacity and potential legal liabilities.
- Market Reaction Swift: Following the earnings announcement, Ardent's stock fell by $4.75, reflecting market concerns over the company's financial health and severely impacting investor trust in future profitability and management integrity.
Analyst Views on ARDT
Wall Street analysts forecast ARDT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARDT is 13.73 USD with a low forecast of 10.00 USD and a high forecast of 17.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Analyst Rating
8 Buy
4 Hold
1 Sell
Moderate Buy
Current: 8.630
Low
10.00
Averages
13.73
High
17.00
Current: 8.630
Low
10.00
Averages
13.73
High
17.00
About ARDT
Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.








